Recent data demonstrated that blocking TGFβ signaling with a dominant-negative form of TGFβRI or Smad4 knockdown in human breast cancer cell lines decreased the ability of these cells to generate lung metastases when implanted as mammary tumors in mice [17]. Here, SMAD4 is linked to breast cancer.